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Introduction
Focal articular cartilage lesions in the knee are frequently treated by microfracture or autologous chondrocyte implantation. 1 Treatment failure, is often related to inadequate tissue regeneration. 2 Also, good structural repair at short-term follow-up showed to result in good clinical outcome at later time points. 3, 4 In clinical trials, the success of cartilage regeneration is usually determined by histological evaluation of regenerated tissue obtained from an additional cartilage biopsy from the newly formed tissue. The disadvantages of a cartilage biopsy, and the main reasons for which it has not been introduced as a standard protocol in clinical practice, is the invasive nature of the procedure and the fact that it only provides local information. Therefore, a non-invasive method to determine tissue organization and to assess the distribution of relevant articular cartilage matrix proteins would be of great value in the evaluation of tissue regeneration.
The non-invasive MR imaging technique called dGEMRIC (delayed Gadolinium
Enhanced MRI of Cartilage) can be used to assess the concentration of GAGs in the extracellular cartilage matrix. 5 This technique is based upon the negatively charged ions of the T1-shortening contrast agent gadolinium diethylene triamine pentaacetic acid (Gd-DTPA 2-, Magnevist) that distribute inversely proportional to the concentration of the also negatively charged GAGs in articular cartilage. The Gd-DTPA 2-concentration per voxel is described by means of the dGEMRIC index (T1gd) which is calculated from the 5 different inversion times using a curve fitting method.
In areas with low GAG the calculated T1gd will be low, and vice versa. A good correlation was found between the biochemically determined GAG contents and the related T1gd times in ex vivo studies. 5, 6 In addition, it was shown that the dGEMRIC M A N U S C R I P T
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technique can be used to evaluate the quality of articular cartilage after osteochondral autologous transplantation, high tibial osteotomy and matrix-assisted ACI. [7] [8] [9] [10] [11] In addition to the availability of techniques evaluating the outcome of defect treatment, it is becoming increasingly evident that its success is directly dependent on patient characteristics. 12 Factors such as age and gender of the patient and size, age and location of the focal lesion were shown to influence clinical outcome after regenerative cartilage therapy. 12 However, it is not known to what extent these characteristics also affect the biological repair response.
Therefore, the primary aim of this study was to show that the dGEMRIC technique is able to monitor cartilage repair following regenerative cartilage treatment. We also evaluated to what extent local cartilage repair influences the cartilage quality in the whole knee. Also, specific patient and defect characteristics were evaluated for their influence on cartilage repair. The clinical treatment outcome was assessed using two different questionnaires both validated for the evaluation of the clinical status of patients treated for an articular cartilage lesion.
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The Knee injury and Osteoarthritis Outcome Score (KOOS) was designed to evaluate the short-and long-term follow-up of treatment of knee injury and knee osteoarthritis. Recently this questionnaire was validated to measure the clinical M A N U S C R I P T
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6 condition in patients after regenerative cartilage surgery. 15 The KOOS consists of 5 subdomains; symptoms, pain, activities of daily living, function in sport and recreation and knee-related quality-of-life. The KOOS score per subdomain (score 0-100) was calculated using the free available scoring sheet on the KOOS website (http://www.koos.nu/).
The Lysholm questionnaire was initially designed to evaluate the functional disabilities resulting from ligamentous injury. Recently, this questionnaire has also been validated to asses articular cartilage damage. 16 The questionnaire consists of 8 domains (pain, instability, locking, swelling, limping, walking stairs, squatting and keeping support) and translates to a score between 0 and 100 (normal knee function).
Statistical analysis
All statistical analysis was performed using SPSS statistical software version 15.0 (Chicago, USA). Internal consistency of the segmentation process was performed by the Crohnbach's alpha and the reliability using the intraclass correlation coefficient (ICC). At baseline, the T1gd ranged from 365-484ms for the different ROIs (defect 365±46, articulating 484±125, treated 421±48, other1 422±60, other2 448±68, whole 432±54).
The KOOS scores at baseline were lowest for the sports and quality of life subdomains (pain 59±19, activity of daily living 65±20, symptoms 62±18, sports 27±22, quality of life 24±15). The baseline Lysholm score was 48±21 points.
Except for the articulating ROI, the T1gd indices at 3 months after surgery were slightly, but statistically non-significantly, decreased compared to the baseline values (Table 2 , defect 362±54, articulating 481±171, treated 407±68, other1 411±61, other2 419±55, whole 415±58). After 12 months follow-up, the T1gd of the defect and the articulating ROI showed the largest, statistically significant (p<0.01) improvement from baseline (defect 468±91, articulating 622±241), which was also clearly visible on the dGEMRIC images ( Figure 2 ). In addition, the T1gd of the other ROIs (treated 481±91, other1 503±85, other2 680±63, whole 484±67) also showed a clear, and statistically significant (p<0.01), improvement from baseline.
At 3 months after surgery, the clinical scores did not show a statistically significant change from baseline (Table 2) . However, at 12 months follow-up all but 3 patients showed clearly improved clinical scores. Improvement from baseline was noted on M A N U S C R I P T
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10 the Lysholm, the KOOS subdomains and the KOOS overall scores (p<0.01) ( Table   2 ).
Regression analysis; effect of defect treatment on distant cartilage quality All variables in the regression analysis had a normal distribution (normality tests p>0.358) and no multicollinearity or autocorrelation were found (variance inflation factor, 1.000; Durbin-Watson range, 2.199-2.510). Also scatterplots of model residuals showed normal residual distribution and homoscedasticity of residuals.
The increase in T1gd after 12 months at the defect ROI was significantly related to the T1gd increase of the other ROIs in the joint ( Table 3 ). The B-values ranged from 0.787-0.567 indicating that for each millisecond increase in T1gd at the treated defect after 12 months, the T1gd of the cartilage at another location in the joint increased with 0.787-0.567 ms.
Multiple regression analysis showed that the patient characteristics (gender, patient age, defect age and defect size,) did not influence (p>0.070) the improvement in T1gd after 12 months for the defect ROI. However, defect size and patient age were shown to influence the improvement in T1gd of the whole ROI at 12 months after surgery. A defect size >3 cm 2 was related to 58±24 less increase (p=0.024) in T1gd of the joint as a whole after 12 months compared to defects <3 cm 2 and in patients <30 years old a 152±47 stronger increase (p=0.005) in the T1gd was found compared to those >30 years old at 12 months after surgery.
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Discussion:
This study evaluated the feasibility of noninvasive monitoring by dGEMRIC of defect repair and general tissue integrity of cartilage in the joint after cartilage repair surgery. The dGEMRIC scanning technique was useful in detecting local cartilage repair in a focal defect one year after treatment, which was accompanied by clearly improved clinical scores. In addition, local improvement of T1gd was directly related to the improvement of cartilage quality in other joint compartments. Also, patient age and defect size influenced the treatment response of the articular cartilage in the whole knee.
The International Cartilage Research Society has recently published several guidelines for histological and MRI based evaluation of cartilage repair studies. 17, 18 Histological evaluation of newly formed cartilage provides information on the structural organization and can help to understand the biological success of tissue regeneration. 17 Disadvantages of histological evaluation are the time consuming processing and the small volume of tissue that can be analyzed. Moreover, the invasive nature of the necessary biopsy makes longitudinal follow-up less desirable from an ethical point of view. Contrast-enhanced MRI scanning protocols, such as dGEMRIC, are able to represent tissue structure and can be readily applied in a longitudinal follow-up. Moreover, with MRI the whole joint can be assessed instead of only small tissue volumes after biopsy.
Overall the dGEMRIC technique is reliable as repeated measurements show a good reproducibility. [19] [20] [21] Also the coefficient of variation in the bulk T1gd for certain cartilage ROIs was 5%, ranging from 4.2%-5.5% for femur and tibia cartilage respectively. 19 However, recent reports question the robustness of the physical M A N U S C R I P T
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properties at which the dGEMRIC technique is based on. The measurement of bulk T1gd values from articular cartilage 1.5 hour after scanning is based on the assumption of a steady state concentration gradient at that time. 14 However, recently it was shown that the depth-wise concentration gradient of Gd-DTPA 2-is continuously changing which could make bulk ROI measurements less reliable. 22 In addition, the diffusion time of Gd-DTPA 2-seemed slower than previously assumed and the distribution of Gd-DTPA 2-is also influenced by the collagen content of the articular cartilage. 23 These observations should be taken into account when dGEMRIC data is being evaluated and one should be cautious to directly relate measured T1gd to tissue GAGs. Abovementioned issues are a limitation of the dGEMRIC technique and manuscripts that directly relate dGEMRIC findings to tissue GAG. In addition this study could have been strengthened when also other quantitative MRI techniques, such as T2 mapping or proton density sequences, were added to the analysis. In addition, such scanning sequences are more reliable in the assessment of a focal lesion and therefore will lead to a more precise segmentation of the cartilage in the focal defect area. This could prevent from an erroneous baseline T1gd values of the defect ROI resulting from a segmentation that includes limited amounts of thegadolinium containing-synovial fluid in the defect. Also longer follow-up would have provided more information on the use of non-invasive evaluation tools, such as dGEMRIC, for the evaluation of articular cartilage following cartilage repair.
To our knowledge one study also compared the T1gd values measured in a focal cartilage lesion to those 1 year after matrix-associated ACI. 9 However, the main outcome parameter of that study was to evaluate the zonal distribution of GAGs, using dGEMRIC, in normal and repair tissue. Therefore, the study may have been Several other groups already used dGEMRIC to evaluate articular cartilage after ACI, but focussed on differences between repair and native tissue, the zonal organization of the newly formed tissue or only performed post-surgery dGEMRIC without baseline measurements. 7, 9, 11, 24 Considering the large variation in T1gd times between patients, it is difficult to define a consensus T1gd that represents acceptable or good quality cartilage after regeneration. Therefore, patient specific baseline measurements are essential when cartilage quality following regenerative surgery is a relevant outcome in a longitudinal study.
During the different phases of cartilage regeneration the organization of matrix constituents and water content change continuously. 18 These factors influence the T1 relaxation time of the newly formed tissue and most likely lead to differences of the measured T1 relaxation times in repair tissue compared to the reference healthy or degenerated cartilage. 18 This should be taken into account when cartilage is being evaluated with the dGEMRIC technique. A direct comparison, using only postcontrast imaging, between repair tissue and other locations in the joint could, therefore, introduce erroneous interpretation of the data and does not represent the true GAG content in articular cartilage. 18 The delta relaxation rate (∆R1 = 1/T1 precontrast -1 / T1(Gd)) corrects for the differences in precontrast T1 and is preferred when different locations in the joint are being evaluated and compared in a cross-sectional study design. 18 However, per location in the joint (either repair or healthy reference tissue) the correlation between the T1gd and ∆R1 is high and M A N U S C R I P T
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14 separate interpretation of both outcome variables lead to similar conclusions. 25 The absence of pre-contrast imaging, in this study, combined with a longitudinal evaluation at predefined locations does, for abovementioned reason, not influence data interpretation nor change the final conclusions. In addition, patient comfort will decrease when also a precontrast MRI scan was performed as scanning time would be twice as long.
The clinical benefit following ACI and microfracturing is influenced by specific characteristics of the defect or patient. 4, 12, [26] [27] [28] Also, in specific cases one technique may perform better than the other one does. 4, 12, 27, 29 In this study, the size of the defect and age of the patient showed a direct relation to the overall improvement in
T1gd of the articular cartilage in the knee, at 12 months after surgery. This implies that specific biological characteristics of the defect and patient could play a role in the intrinsic repair capacity of the articular cartilage following surgery. The articular cartilage in the knee showed less improvement following cartilage surgery when a large defect (> 3 cm 2 ) had been present. Whether the size of the defect is positively correlated to the severity of disturbance in joint homeostasis remains to be seen, however, the presence of an articular cartilage defect has been shown to induce joint cartilage degeneration. 30 It has also been shown that larger defects, if left untreated, are related to an increased cartilage volume loss. 31 Age influenced the improvement in T1gd following cartilage surgery in this study. Younger patients could be more sensitive for a regenerative response due to the senescence of cells and tissues related to the effects of aging.
32
Based on macroscopic and biochemical evaluation, the treatment of an articular cartilage defect has been related to a decrease in degenerative characteristics at other joint locations. 30 In this study we showed, using regression analysis, that defect M A N U S C R I P T
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treatment is related to the improvement of the T1gd at other locations in the joint which could imply improved cartilage quality. These findings underline the importance of the concept of joint homeostasis and the role for early detection and intervention. The presence of an articular defect should be regarded as indicative of a joint disease rather than a local problem. Timely treatment has been shown to improve clinical outcome, i.e. timely restoration of the joint homeostasis improves the regenerative response of the whole joint. 4, 12 Using dGEMRIC, such changes can be monitored thereby providing a reliable imaging tool for the evaluation of cartilage quality in the whole joint following cartilage repair.
In conclusion, this study demonstrates that the dGEMRIC technique can be used to longitudinally measure changes in T1gd following cartilage repair surgery. Also, using dGEMRIC we showed that patient age and defect size influence the improvement in Title:
dGEMRIC at baseline and 12 months follow-up.
Legend:
The blue pixels represent a high T1gd (1000 ms) while a low T1gd of 0 is labeled as red. At the preoperative situation a clear change in signal (from yellow to red) is visible at the site of the lesion when compared to the rest of the knee. At 12 months after surgery the overall signal in the knee is improved (more blue-green) with a clear signal improvement at the treated defect site.
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25 Tables and table legends   Table 1 :
Title: Baseline characteristics.
Legend: *defect age from Chondron treatment patients is missing. 
Patients (n=31) Gender
